Emerging from the UK, retatrutide, a novel peptide , is creating considerable interest within the healthcare community regarding its potential for body management . This dual GIP and GLP-1 target agonist looks to deliver a considerable advantage over existing therapies, showing encouraging results in initial clinical studies . Researchers believ… Read More